Missouri and Illinois Resume Use of Johnson & Johnson (Janssen) Vaccine

Missouri and Illinois COVID-19 vaccinators have resumed the use of the Johnson & Johnson (J&J) COVID-19 vaccine. On April 13, the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) paused the use of the J&J vaccine due to rare blood clots reported in six cases involving women under the age of 50, out of more than 7.2 million shots given. This pause allowed the CDC’s Advisory Committee on Immunization Practices to further investigate the reported side effects. The Committee concluded that the vaccine is safe and effective at preventing COVID-19, and that its benefits outweigh the known risks.

Call your doctor if you have concerns or got the J&J COVID-19 vaccine and have the following symptoms within 3 weeks of getting it: headache, stomach pain, leg pain, and/or shortness of breath (trouble breathing).

For more information, read the CDC and FDA’s joint press release here, Missouri Department of Health and Senior Services’ Johnson & Johnson FAQ here and Illinois Department of Public Health’s COVID-19 vaccine FAQ here.

Latest News

    No feed items found.

Wear 2 Masks. Wash Your Hands. Watch Your Distance.

HOW IT SPREADS

Touching icon

TOUCHING

sneezing icon

SNEEZING

coughing icon

COUGHING

sharing utensils icon

SHARING UTENSILS

dirty surfaces icon

DIRTY SURFACES

WHO IS MOST AT RISK

  • Elderly
  • Pregnant
  • Those with chronic conditions such as diabetes, heart disease, lung disease or weakened immune systems